These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27343996)

  • 21. A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.
    James NG; Digman MA; Ross JA; Barylko B; Wang L; Li J; Chen Y; Mueller JD; Gratton E; Albanesi JP; Jameson DM
    Biochim Biophys Acta; 2014 Jan; 1840(1):315-21. PubMed ID: 24016602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.
    Lionello VM; Nicot AS; Sartori M; Kretz C; Kessler P; Buono S; Djerroud S; Messaddeq N; Koebel P; Prokic I; Hérault Y; Romero NB; Laporte J; Cowling BS
    Sci Transl Med; 2019 Mar; 11(484):. PubMed ID: 30894500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Dominant Mutation in BIN1 Gene Causing Mild Centronuclear Myopathy Revealed by Myalgias and CK Elevation.
    Garibaldi M; Böhm J; Fattori F; Koch C; Surace C; Ottaviani P; Laschena F; Laporte J; Bertini E; Antonini G; Romero NB
    J Neuromuscul Dis; 2016 Mar; 3(1):111-114. PubMed ID: 27854204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation.
    Böhm J; Yiş U; Ortaç R; Cakmakçı H; Kurul SH; Dirik E; Laporte J
    Orphanet J Rare Dis; 2010 Dec; 5():35. PubMed ID: 21129173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cells Control BIN1-Mediated Membrane Tubulation by Altering the Membrane Charge.
    Gowrisankaran S; Wang Z; Morgan DG; Milosevic I; Mim C
    J Mol Biol; 2020 Feb; 432(4):1235-1250. PubMed ID: 31857086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
    Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
    PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy.
    Ceyhan-Birsoy O; Agrawal PB; Hidalgo C; Schmitz-Abe K; DeChene ET; Swanson LC; Soemedi R; Vasli N; Iannaccone ST; Shieh PB; Shur N; Dennison JM; Lawlor MW; Laporte J; Markianos K; Fairbrother WG; Granzier H; Beggs AH
    Neurology; 2013 Oct; 81(14):1205-14. PubMed ID: 23975875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Roma founder
    Cabrera-Serrano M; Mavillard F; Biancalana V; Rivas E; Morar B; Hernández-Laín A; Olive M; Muelas N; Khan E; Carvajal A; Quiroga P; Diaz-Manera J; Davis M; Ávila R; Domínguez C; Romero NB; Vílchez JJ; Comas D; Laing NG; Laporte J; Kalaydjieva L; Paradas C
    Neurology; 2018 Jul; 91(4):e339-e348. PubMed ID: 29950440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BIN1 modulation in vivo rescues dynamin-related myopathy.
    Lionello VM; Kretz C; Edelweiss E; Crucifix C; Gómez-Oca R; Messaddeq N; Buono S; Koebel P; Massana Muñoz X; Diedhiou N; Cowling BS; Bitoun M; Laporte J
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation.
    Claeys KG; Maisonobe T; Böhm J; Laporte J; Hezode M; Romero NB; Brochier G; Bitoun M; Carlier RY; Stojkovic T
    Neurology; 2010 Feb; 74(6):519-21. PubMed ID: 20142620
    [No Abstract]   [Full Text] [Related]  

  • 32. Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells.
    González-Jamett AM; Baez-Matus X; Olivares MJ; Hinostroza F; Guerra-Fernández MJ; Vasquez-Navarrete J; Bui MT; Guicheney P; Romero NB; Bevilacqua JA; Bitoun M; Caviedes P; Cárdenas AM
    Sci Rep; 2017 Jul; 7(1):4580. PubMed ID: 28676641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy.
    Nicot AS; Toussaint A; Tosch V; Kretz C; Wallgren-Pettersson C; Iwarsson E; Kingston H; Garnier JM; Biancalana V; Oldfors A; Mandel JL; Laporte J
    Nat Genet; 2007 Sep; 39(9):1134-9. PubMed ID: 17676042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation.
    Bitoun M; Bevilacqua JA; Eymard B; Prudhon B; Fardeau M; Guicheney P; Romero NB
    Neurology; 2009 Jan; 72(1):93-5. PubMed ID: 19122038
    [No Abstract]   [Full Text] [Related]  

  • 36. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
    Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
    J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult centronuclear myopathies: A hospital-based study.
    Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
    Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamin 2 the rescue for centronuclear myopathy.
    Demonbreun AR; McNally EM
    J Clin Invest; 2014 Mar; 124(3):976-8. PubMed ID: 24569368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility gene card for: Centronuclear and myotubular myopathies.
    Biancalana V; Beggs AH; Das S; Jungbluth H; Kress W; Nishino I; North K; Romero NB; Laporte J
    Eur J Hum Genet; 2012 Oct; 20(10):. PubMed ID: 22617344
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutations in dynamin 2 cause dominant centronuclear myopathy.
    Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
    Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.